This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignee: Roche Diabetes Care, Inc.. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: Chinmay Uday Manohar: An Emerging Innovator in the Pharmaceutical Industry
Introduction
Chinmay Uday Manohar is an accomplished professional located in the United States, making strides in the pharmaceutical sector. He currently works for F. Hoffmann-La Roche AG, a prominent company known for its innovative healthcare solutions. Although he has not yet registered any patents, his contributions within the industry continue to be influential.
Latest Patents
As of now, Chinmay Uday Manohar holds no patents. However, it is essential to recognize that innovation comes in many forms, and the impact of an inventor can often be seen beyond the realm of patented inventions.
Career Highlights
Working at F. Hoffmann-La Roche AG, Chinmay has the opportunity to be involved with cutting-edge research and development initiatives. His efforts in this competitive environment have enabled him to collaborate with some of the industry's best minds.
Collaborations
During his tenure at F. Hoffmann-La Roche AG, Chinmay has collaborated with notable colleagues such as David L. Duke and Christian Ringemann. These collaborations demonstrate his ability to work effectively within a team and contribute to high-impact projects in the pharmaceutical sector.
Conclusion
Chinmay Uday Manohar is an emerging figure in the pharmaceutical industry, positioned at a company renowned for its commitment to innovation. While he may not currently hold any patents, his work and collaborations have the potential to shape future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
